| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000021815 |
| Receipt No. | R000025145 |
| Official scientific title of the study | The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetes |
| Date of disclosure of the study information | 2016/06/10 |
| Last modified on | 2016/04/07 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetes | |
| Title of the study (Brief title) | The effect of omarigliptin on glucose excursion using CGM in the elderly patients with T2DM | |
| Region |
|
|
| Condition | ||
| Condition | type 2 diabetes | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess efficacy and safety of omarigliptin in the elderly patients with type 2 diabetes mellitus. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | glucose excursion using continuous glucose monitoring |
| Key secondary outcomes | fasting and postprandial glusoce
fasting and postprandial CPR fasting and postprandial glucagon LDL-C TG HDL-C |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | NO |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | omarigliptin
12.5mg or 25mg |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients with type 2 diabetes, 60 years of age and older
|
|||
| Key exclusion criteria | Type 1 diabetes
Severe liver dysfunction The subjects found offensive by attending physicians for this clinical research |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Yukio Horikawa |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Endoclinology |
| Address | 1-1 yanagido, gifu, japan |
| TEL | 058-230-6000 |
| yhorikaw@gifu-u.ac.jp | |
| Public contact | |
| Name of contact person | Yukio Horikawa |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Department of Endoclinology |
| Address | 1-1 yanagido, gifu, japan |
| TEL | 058-230-6000 |
| Homepage URL | |
| yhorikaw@gifu-u.ac.jp | |
| Sponsor | |
| Institute | Department of Endoclinology, Gifu University Graduate School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Endoclinology, Gifu University Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Yamada hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000025145 |